Inhibition of the Cold Activation of Factor VII and the Prothrombin Time
Open Access
- 1 May 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 81 (5) , 618-622
- https://doi.org/10.1093/ajcp/81.5.618
Abstract
Normal whole blood, collected and stored in borosilicate or commercial siliconized borosilicate tubes at 4°C, undergoes a timedependent activation of Factor VII and a shortening of the prothrombin time (PT). Addition of inhibitors to Factor XII fragments (corn Hageman factor inhibitor, CHFI) or to activated Factor XII (Cytochrome-C) inhibited in a concentration-dependent way the cold-promoted activation of Factor VII and the shortening of the PT. When celite was added to whole blood in polypropylene tubes at 4°C, Factor VII was activated and the PT shortened. Preincubation of celite with CHFI or Cytochrome-C prevented the activation of Factor XII and the subsequent activation of Factor VII and the PT. These studies demonstrate the importance of Factor XII in the cold activation of Factor VII and shortening of the PT and indicate that inhibitors to activated Factor XII or XII fragments are useful in inhibiting in vitro shortening of the PT. These findings suggest that the development of a collection tube that prevents contact activation also would inhibit adequately the cold-promoted activation of the PT and Factor VII.Keywords
This publication has 12 references indexed in Scilit:
- Misinterpretation of Prothrombin Time in Warfarin AnticoagulationAnnals of Internal Medicine, 1981
- Activation of Human Factor VII in Plasma and in Purified SystemsJournal of Clinical Investigation, 1979
- Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VIIThrombosis Research, 1978
- Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor)Biochemistry, 1977
- ACTIVATION OF BOVINE FACTOR-VII BY HAGEMAN-FACTOR FRAGMENTS1977
- Hereditary Angioedema: the Clinical Syndrome and Its ManagementAnnals of Internal Medicine, 1976
- The hageman factor dependent pathways of human plasmaMicrovascular Research, 1974
- Inhibition of Hageman factor activationJournal of Clinical Investigation, 1968
- Effect of oral contraceptives on vitamin K—dependent clotting activtiyClinical Pharmacology & Therapeutics, 1967
- The Mechanism of Action of Human Accelerator Globulin and Its Relation to Other Clotting FactorsBlood, 1954